Google Alum’s AI startup raises $24 million for biotech work
[ad_1]
European biotech startup Cradle raised $24 million, gaining funds for its effort to use AI to help scientists design and engineer proteins faster and more cost-effectively.Index Ventures led the Series A round, joined by Kindred Capital, Chris Gibson, the co-founder of Recursion Pharmaceuticals Inc., and Tom Glocer, the former chief executive officer of Thomson Reuters Corp. and a Merck & Co. board member, Cradle said Tuesday. The startup has raised a total of $33 million so far, including a seed round last year. Cradle harnesses generative artificial intelligence to help create proteins beyond what exists in nature. It's working on more than a dozen projects to engineer a wide range of protein sequences and 3D structures for enzymes, vaccines, lab-grown food and other materi...